Last month, Ida Tin raised $20 million for her period-tracking app.
A few weeks earlier, the telemedicine startup Nurx brought in $5.3 million for prescribing birth control through an app, and the company Ava rounded up $9.7 million for a wearable fertility tracker. Add to that some notable raises from earlier this year — $200 million in private equity funding for the fertility tech company Prelude and $14.7 million for its competitor Progyny.
It was a lot of money in a short amount of time for women's health — an area once seen by investors as "niche."
"It's interesting to see how the world has moved since we started talking to investors three or four years ago," Tin, CEO of the period-tracking app Clue, told Mashable. "Back then, people would say it feels like a niche product, which it obviously isn't since it's relevant to half the world. We don't hear that anymore." Read more...
More about Women In Tech, Investor, Healthcare And Medicine, Health Tech, and Womens Health from Mashable http://ift.tt/2hthCkE
0 التعليقات:
إرسال تعليق